Publication | Closed Access

The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators

Inhibitory ActivitySignal TransductionMedicineReceptor Tyrosine KinaseDeacetylase Inhibitor PanobinostatMechanism Of ActionMtor InhibitorPharmacotherapyAnti-cancer AgentPharmacologyCell BiologyCell SignalingCxcr4-mediated ResistanceTumor Biology